Does portal writing style contribute to disparities in clinician response?

• by Andrea Surnit

• August 27, 2026

FDA expands bladder cancer therapy approval

The expansion offers another treatment option for patients with high-grade tumors following BCG failure.

• by Mouj Hijazi

• October 14, 2026

• 3 min

FDA approves first therapy for symptomatic dermographism

The oral BTK inhibitor produced a complete hive response in 29.3% of treated patients at week 12.

• by Teraya Smith

• October 7, 2026

• 2 min

AI diagnostics and what clinicians can verify in oncology

"The more AI changes what we do … the less able we are to check it.”

• by Lisa Astor

• October 1, 2026

• 8 min